Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Strides Pharma Science Ltd.

NSE: STAR | BSE: 532531 | ISIN: INE939A01011 | Industry: Pharmaceuticals
| Strong Performer, Under Radar

634.7500 -15.15 (-2.33%)

NSE May 02, 2025 15:31 PM

62.10% Fall from 52W High

Volume: 331.5K

Strides Pharma Science Ltd.

10 May 2024

634.75

-2.33%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Strides receives USFDA approval for Sevelamer Carbonate Tablets, 800mg

More from Strides Pharma Science Ltd.

Recommended

Five Interesting Stocks Today - May 02, 2025

The Baseline | 02 May 2025

Market closes flat, Ami Organics' Q4 net profit beats Forecaster estimates by 30%

Trendlyne Marketwatch | 02 May 2025

Earnings Call Transcript - Q1FY21 for Strides Pharma Science